Zalicus To Merge With Epirus Biopharmaceuticals

Zalicus Inc. (Nasdaq: ZLCS) will merge with Epirus Biopharmaceuticals. The stock price leaped 44 cents to $1.47.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.